Cargando…
Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing
Increased production of fetal hemoglobin (HbF) can ameliorate the severity of sickle cell disease and β-thalassemia. BCL11A has been identified as a key regulator of HbF silencing, although its precise mechanisms of action remain incompletely understood. Recent studies have identified pathogenic mut...
Autores principales: | Shen, Yong, Li, Rick, Teichert, Kristian, Montbleau, Kara E., Verboon, Jeffrey M., Voit, Richard A., Sankaran, Vijay G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530301/ https://www.ncbi.nlm.nih.gov/pubmed/34634037 http://dx.doi.org/10.1371/journal.pgen.1009835 |
Ejemplares similares
-
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
por: Basak, Anindita, et al.
Publicado: (2020) -
Transcriptional silencing of fetal hemoglobin expression by NonO
por: Li, Xinyu, et al.
Publicado: (2021) -
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
por: Bjurström, Carmen F, et al.
Publicado: (2016) -
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
por: Psatha, Nikoletta, et al.
Publicado: (2018) -
POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression
por: Gudmundsdottir, Bjorg, et al.
Publicado: (2018)